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Abstract
microRNAs (miRNAs) are short non-coding RNAs with regulatory functions in various biological processes including cell
differentiation, development and oncogenic transformation. They can bind to mRNA transcripts of protein-coding genes
and repress their translation or lead to mRNA degradation. Conversely, the transcription of miRNAs is regulated by proteins
including transcription factors, co-factors, and messenger molecules in signaling pathways, yielding a bidirectional
regulatory network of gene and miRNA expression. We describe here a least angle regression approach for uncovering the
functional interplay of gene and miRNA regulation based on paired gene and miRNA expression profiles. First, we show that
gene expression profiles can indeed be reconstructed from the expression profiles of miRNAs predicted to be regulating the
specific gene. Second, we propose a two-step model where in the first step, sequence information is used to constrain the
possible set of regulating miRNAs and in the second step, this constraint is relaxed to find regulating miRNAs that do not
rely on perfect seed binding. Finally, a bidirectional network comprised of miRNAs regulating genes and genes regulating
miRNAs is built from our previous regulatory predictions. After applying the method to a human cancer cell line data set, an
analysis of the underlying network reveals miRNAs known to be associated with cancer when dysregulated are predictors of
genes with functions in apoptosis. Among the predicted and newly identified targets that lack a classical miRNA seed
binding site of a specific oncomir, miR-19b-1, we found an over-representation of genes with functions in apoptosis, which
is in accordance with the previous finding that this miRNA is the key oncogenic factor in the mir-17-92 cluster. In addition,
we found genes involved in DNA recombination and repair that underline its importance in maintaining the integrity of the
cell.
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Introduction
miRNAs are small endogenous RNAs with a length of about
22 nt with gene regulatory functions and are found in plants and
animals [1]. Unlike other classes of small RNAs, miRNAs undergo
a characteristic biogenesis which consists of a transcript folding
back on itself to form a distinctive hairpin structure [2]. After
processing, miRNAs form a complex with an Argonaute protein,
pair with the target mRNA and induce post-transcriptional
repression of the gene product [1]. Since more than half of the
human protein-coding genes seem to have conserved miRNA
pairing sites in their 39-UTR [3], it is difficult to find a biological
process or pathway which is not at all influenced by regulation
from miRNAs [1]. It is most likely that the interactions of miRNAs
and mRNAs are context-specific as miRNAs are known to play
important roles in differentiation, development, cancer and more
[4–8]. Knowing which miRNA regulates which gene at a certain
time and location is crucial not only to understand gene regulation
but also for a systems biology account of the cell. Two mechanisms
of post-translational repression of mRNAs by miRNAs are well-
described for metazoans: 1) at sites with high complementarity
between mRNA and miRNA, a miRNA can bind to the mRNA
and induce mRNA cleavage with the help of an Argonaute protein
[1,9]; 2) the miRNA induces translational repression or mRNA
destabilization, e.g., by inhibition of translation initiation and
poly(A) shortening, or both [1,10]. In animals, the second
mechanism, which requires less sequence complementarity
between mRNA and miRNA, is used more often [1].
Approaches to elucidate miRNA-mRNA associations can be
classified into two principal classes: 1) solely sequence-based
approaches and 2) expression data-based approaches which often
include sequence features. While the sequence-based approaches
focus on one-to-one relationships, the data-based methods are
more flexible to also search for many-to-one or one-to-many
relationships. The sequence-based miRNA target prediction
algorithms focus on predicting direct targets of miRNAs based
on sequence similarities, especially the seed sequence, and
evolutionary conservation. The target prediction problem is hard
and the prediction accuracy is currently still low. The shortness of
seed sequences leads to high numbers of false positive predictions
[1] and low sensitivity. State-of-the-art target predictors include
features additional to the seed region in the 39-UTR of the
mRNA, e.g., conservation of the site across related species
[3,11,12]. However, this seems to be insufficient in reducing the
number of false-positives, plus, in the case of sequence conserva-
tion, misses species-specific poorly conserved candidate sites.
Beyond sequence complementarity, Grimson and co-authors
[13] report five features of site context that improve binding site
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efficacy and others have also reported on the impact of structural
factors on target recognition [14,15]. Very recently, additional
mechanisms of miRNA-mRNA interactions have been shown to
affect mRNA expression levels [16]. While Elefant et al. showed
that seed pairing is the dominant mechanism in down-regulating
miRNA target genes (81% of binding sites), they also found
predicted functional 39-compensatory binding sites in a consider-
able fraction of target genes (18.6%). 39-compensatory binding
sites are characterized by insufficient 59 seed pairing which is
compensated by extensive 39 end pairing. An additional 0.5% of
down-regulated targets were predicted to host centered sites.
These sites lack both perfect seed pairing and 39-compensatory
binding, but allow for extensive pairing (11–12 contiguous pairs) at
the center of the miRNA. Non-canonical binding mechanisms are
not yet considered by current miRNA target prediction algorithms
and thus raise hope that prediction accuracies will improve in the
near future.
Expression data-based approaches usually start from high
dimensional miRNA and mRNA expression data. While mere
negative correlations do recover some miRNA-mRNA regulatory
relationships, more powerful approaches have been developed to
make use of paired mRNA-miRNA expression profiles [17,18].
Huang et al. proposed a Bayesian model based on predicted
miRNA targets from TargetScan and miRNA and mRNA
expression data, which tries to account for mRNA expression
given the miRNA expression. This comes down to a feature
selection problem in determining the miRNAs which best predict
the observed mRNA expression profile. A similar approach is
taken by the LASSO, and indeed it has also been shown to be a
valuable approach for deriving functional miRNA-mRNA inter-
actions from expression data, outperforming plain correlations
[19].
Another elegant approach has been proposed by Betel et al.
[20]. Therein, support vector regression is used to score the local
and global context of a miRNA binding site after having been
trained on miRNA transfection experiments. The algorithm can
predict non-canonical (lacking perfect seed binding), non-evolu-
tionary conserved sites and allows for multiple regulators of the
same gene. However, it requires a negative association between
miRNA and mRNA and needs experimental data for training.
Even in the absence of miRNA expression data, Radfar et al.
[21] showed that intronic miRNA expression can be inferred from
host gene expression. They classify miRNAs into the ones tightly
co-regulated with their host gene, those transcribed from the same
promotor but the mRNA itself is targeted by one or several
miRNAs and those which have independent promotors.
Two advantages of the expression data-based, and expression
data- and sequence integrating approaches are a) they allow to
study regulatory feedback, and b) they can account for multiple
regulators for the same gene. With respect to a), miRNAs regulate
the expression of genes via mediating the degradation or
translational repression of mRNAs. Vice versa the expression of
the miRNAs themselves is under the control of genes like
transcription factors and their mediators. Together this yields a
bidirectional regulatory interplay of gene expression and miRNA
expression. Complementary target binding based on sequence
features can at most explain one direction. With respect to b),
regulators often work in teams. Early computational approaches to
uncover regulation of gene expression by miRNAs on a large scale
have focused on one-to-one relationships between a gene (mRNA)
and a miRNA [22–24]. This simplification does not reflect the true
state of nature. It is known that one miRNA can regulate the
expression of several genes that have the same miRNA binding site
in their 39-UTR, and that some genes carry predicted binding sites
for more than one miRNA [25]. Therefore it is likely that these
genes are also regulated by more than one miRNA. Whether
several miRNAs regulate the expression of a gene in concert or
whether individual miRNAs are used context- and/or time-
specific has not yet been studied extensively. More recent
approaches consider multiple miRNAs regulating the same gene
[18,19].
Two further points remain to be addressed: a) miRNAs can also
increase gene expression. While most research focused on
regulation where the miRNA decreases the amount of mRNA
or protein, there is evidence that a miRNA can also increase the
amount of mRNA or protein, e.g in quiescent cells, while in
proliferating cells they are more likely to repress translation
[26,27]. Current approaches neglect this possibility and restrict
themselves to negative associations of miRNAs and mRNAs. b)
Indirect regulation. Besides the direct interaction of a miRNA and
a gene, a miRNA can also act on an intermediate regulatory
molecule which then affects a functional target mRNA. Thus,
increased miRNA levels may lead to repression or elevation of
gene expression levels when intermediate players are involved.
This type of regulation is also neglected when focusing on negative
interactions. Therefore, data-driven methods to identify functional
miRNA-mRNA interactions should not only focus on perfect seed
pairing and negative associations but allow for the full spectrum of
regulatory mechanisms.
In this manuscript, we first show that entire mRNA expression
profiles or large parts of them can be reconstructed only from the
expression of miRNAs and vice versa, a precondition that has not
been shown in previous regression based approaches. Next, we
propose a two-step computational model that in its first step uses
binding site information from miRNA target prediction algorithms
(TargetScan [3], microCosm [12], PicTar [28], and DIANA/
microT [29]) and in the second step, we release this constraint and
allow all remaining miRNAs as predictors of gene expression. In
this procedure, we give preference to the miRNAs having a
matching seed sequence, but also allow for mechanisms that do
not rely on perfect seed binding. Thus we are able to discover new
interactions which would be overlooked by data-driven computa-
tional models described so far. In addition, we also compute a
reverse model where genes predict the expression of miRNAs,
which allows to build bi-directional networks of miRNA-mRNA
regulation.
Results
Predicting Gene from miRNA Expression
We exemplify our method using the NCI-60 panel of human
cancer cell lines. It holds 59 samples for which both gene and
miRNA expression profiles are available. After a filtering step to
remove genes and miRNAs that vary little across samples, we used
311 miRNA expression levels and 4,878 gene expression levels to
study the functional interactions between both types of molecules.
First, we identified miRNA predictors for the expression of all
4,878 genes in the analysis. We applied least angle regression
(LARS) [30], a computationally efficient method that combines
predictive linear regression in high dimensions with the selection of
small sets of predictors. Independently for all 4,878 genes, one
regression model was learned using all 311 miRNAs as possible
predictors. We generated predictions of gene expression in 10-fold
cross-validation, and recorded mean squared errors (cv-MSE)
along with all miRNAs identified as predictors.
The procedure produces regression models and lists of
candidate predictors for all mRNAs. However, some of the
regression models have a poor predictive performance in cross-
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validation. In order to identify genes whose expression can be
predicted only from miRNA expression we contrasted observed
prediction errors (cv-MSEs) with simulated distributions of cv-
MSEs that arise, if the expression profiles are not properly
paired. We did this by running the regression analysis on data
where the samples are randomly permuted in one data set such
that ‘‘paired’’ samples no longer stem from the same cell line. In
other words, we predicted the expression profile of a cell line
from the miRNA profile of another cell line, which can only
result in random predictions. For every predicted gene, we
learned 100 models with permuted pairings yielding 487,800
randomized models. The cv-MSE was recorded across the 100
permutations and an empirical p-value was calculated by
counting the relative frequency of permutation based cv-MSEs
that were smaller than the cv-MSE of the correctly paired data.
False Discovery Rates (FDR) were estimated from the
distributions of p-values [31] and a list of top ranking models
with FDR ,0.01 was considered for further analysis. This resulted
in a total of 928 genes whose expression could be predicted from
miRNA expression alone (File S1). More statistical details of the
regression modeling and permutation testing are given in the
Methods section below.
Since regression is a prediction algorithm, and least angle
regression tackles the variable selection problem, we first check its
prediction and later the variable selection capabilities. Figures 1
(A) and 1 (B) contrast the observed expression values of the 928
predictable genes with their cross-validation predictions from the
miRNA data. Not only do we see a good agreement of predictions
and observations for each gene individually but also a good
agreement of the clustering structure between measured and
predicted gene expression values. This is further supported by
Figures 1 (C) and 1 (D) that contrast all pairwise correlation
coefficients across measured expression values (left) and predicted
expression values (right). This is remarkable, because the
regression models have been learned for all predicted genes
independently from each other. A more quantitative assessment of
prediction accuracies is given in Figure 2. It shows the distribution
of mean squared cross validation prediction errors across genes.
To make the cv-MSE comparable across genes, it was divided by
the variance of the respective gene, yielding a scaled mean squared
prediction error (cv-SMSE). The figure shows distributions of the
cv-SMSE of the original models (green line) and that of the
corresponding permuted models (black line), while the individual
cv-SMSE values are shown as green respectively black vertical
stripes below the density curves. For the prediction accuracy see
also Table 1 where we refer to the models as unconstrained
models.
Interestingly, the expression of none of the genes could be
optimally predicted by a single miRNA. For all 928 predictable
genes, combinations of several miRNAs (at least 2) improved
prediction emphasizing the extent and importance of functional
miRNA-mRNA interactions in gene regulation.
Integration of Target Sequence Information
Using predictions from four different algorithms (microCosm
[12], TargetScan [3], DIANA/microT, [29], and doRiNA
(formerly PicTar) [28]), we searched for miRNA-gene interactions
predicted by at least two of the four algorithms in our models.
Only 4.9% of predictors included a target sequence. The
observation suggests that functional gene regulation through
miRNAs can not be reduced to direct miRNA-mRNA interac-
tions. However, this observation may also result from modeling
limitations. The expression of modules of miRNAs strongly
correlate suggesting that the expression of these miRNAs
themselves are jointly regulated. In the context of LARS regression
this can lead to the replacement of a functionally regulating
miRNA by a co-expressed but functionally uninvolved miRNA as
predictor [32]. To follow up on this problem, we integrated
sequence based target information in our analysis by allowing only
miRNAs with an annotated target sequence for the predicted
genes as possible predictors. For 4,820 of the 4,878 selected genes,
we found at least one miRNA with a complementary target
sequence. The dimensionality of the regression problems now
strongly varies across predicted genes ranging from only one
miRNA with a matching target sequence to 261 possible
predictors.
The prediction accuracy of the constrained models was lower
than for the unconstrained models, see Table 1, where we refer to
the models as direct target models (DTM). However, we still found
480 genes for which the constrained models yielded significant
predictions (File S2). Interestingly, only 4.8% of genes were
optimally predicted with a single miRNA, for all others
complementing expression information from several miRNAs
increased cross-validated prediction accuracy. The significant
DTMs suggest that in many cases the correlation between gene
and miRNA expression can be attributed to direct interactions.
However, the data also suggests that many miRNAs operate in
concert.
Identification of New Regulators
The reduced predictive performance also indicates that
important predictive information is missed. This is further
supported by a third set of models that is trained on all miRNAs
except those used in the DTMs. These residual models are not
used to predict the measured gene expression values but to predict
the residuals of the DTM. Our intention is to find complementary
predictors to the miRNAs that contain a matching target
sequence. Table 1 indicates that again we found 581 models with
significant predictions of residuals, or gene expression values if no
targeting miRNAs were reported for the gene in the database.
This second step allows for the identification of new regulating
miRNAs, which have not yet been reported to regulate the
response mRNA, and thus creates hypotheses on so far unknown
regulators. Note that the combination of DTMs and residual
models does not reflect the same information as the unconstrained
models. While the predictors of the unconstrained models replace
direct target miRNAs, the predictors of the residual models
complement the predictive information held in the predictors of
the direct target models. In the supporting information section we
provide a list of de novo identified candidate regulator miRNAs for
all 581 genes with significant residual models (File S3).
Focusing on Negative Regulatory Interactions
In the prevalent conception of miRNA-mediated gene regula-
tion, the miRNA is negatively regulating the expression of the
gene. This should be reflected in regression models by negative
regression coefficients. However, in all models discussed so far we
observed both positive and negative coefficients. This might in
part be explained by the observation of Vasudevan and coworkers
[26,27], who report that a miRNA can also increase the amount of
mRNA or protein, and by indirect regulation where an
intermediate regulator is negatively affected by the miRNA which
then leads to an increase of mRNA levels.
However, predictive information does not always reflect that a
miRNA regulates a gene. It can also arise when a gene is co-
expressed with a miRNA. While the second mechanism is
functionally as important as the first, one might still want to focus
on miRNA mediated regulation. This can be done by only
Modeling miRNA-mRNA Interactions
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allowing negative regression coefficients in the direct target
models, yielding a fourth set of models that we call negative
regulation models (NRM). We found 716 significant NRM with a
predictive accuracy that is comparable to that of the original DTM
(Table 1, File S4). Also for the NRM we learned residual models
and provide candidate lists of newly identified functional
regulator-target interactions in the supporting information section
(File S5).
Functional Targets of Oncogenic miRNAs
The NCI-60 data set consists of human cell lines originating
from different cancers. Therefore, we expected to find functional
interactions between oncogenic miRNAs and genes involved in
the genesis and progression of cancer. For a selection of
13 miRNAs with known functions in cancer development
described by Esquela-Kerscher [33], we selected significant
models from the negative regulation and residual models
described above where at least one of these onco-miRNAs
Figure 1. Gene expression can be predicted from miRNA expression with high accuracy. A) Gene expression values. B) Gene expression
values predicted from miRNA expression. C) Correlation of gene expression values. D) Correlation of predicted gene expression values. Besides the
gene expression structure, the correlation structure is well-preserved. Predictions are from unconstrained gene models. In subfigures A and B,
samples are in rows and genes are in columns. Expression values were centered and scaled and color-coded with blue representing low and yellow
high expression values. The subfigures C and D show the gene-by-gene correlation structure of the genes displayed in subfigures A and B. Here,
yellow indicates high correlation and red indicates anti-correlation of genes. The order of genes and samples is the same for all subfigures.
doi:10.1371/journal.pone.0040634.g001
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served as a predictor. Interestingly, on their own these miRNAs
did not predict the expression of their potential targets. This was
only accomplished in concert with other miRNAs. These
complementing predictors are newly identified candidates of
oncogenic miRNAs. They are listed in the supporting informa-
tion section (File S5).
We tested the list of genes that were predicted to be regulated by
individual onco-miRNAs from the negative regulation and
residual models for enrichment of Gene Ontology terms [34].
The results are summarized in Table 2. Most interestingly, genes
that are involved in programmed cell death, regulation of the
apoptotic process and other processes that play a role in tumor
development are significantly over-represented among the pre-
dicted functional targets of many onco-miRNAs, reinforcing their
association with tumorigenesis. Table 2 summarizes enrichment of
GO terms for the predicted targets of all onco-miRNAs.
Among the five most significant Gene Ontology terms which are
over-represented in at least two miRNA target gene sets are
‘programmed cell death’, ‘death’, ‘regulation of apoptotic process’
and ‘DNA recombination’. The target gene sets of miR-19b-1 are
enriched for four of these terms. This miRNA and its targets are
examined in more detail below.
The Onco-miRNA miR-19b-1
miR-19b-1 belongs to the mir-17-92 cluster which is frequently
amplified and over-expressed in lymphomas [33]. miR-19b has
been shown to be the key oncogenic miRNA within the mir-17-92
cluster. It is both necessary and sufficient to promote c-myc
induced B-cell lymphomagenesis through the repression of
apoptosis [35].
We identified 9 genes where miR-19b-1 is one of possibly many
predictors in models that have either positive or negative
coefficients and predictors with complementary seed sequences
(direct target models). Interestingly, in most cases, miR-19b-1 was
not chosen as a single predictor but as a co-predictor that needs to
be complemented with further miRNAs in order to predict gene
expression.
In models that were learned on the residuals of the direct target
models, we found 14 genes with miR-19b-1 in their list of
predictors, suggesting that the prominent role of miR-19b-1 in
oncogenesis might not be restricted to its direct action as a
silencing miRNA. This also becomes apparent in Figure 3 that
compares the observed expression of functional miR-19b-1 targets
(left) to their predicted expression using only miR-19b-1 as
predictor (middle) and predictions using miR-19b-1 together with
the identified complementary miRNA predictors (right). Whereas
the prediction of gene expression values with miR-19b-1 alone is
very poor, the prediction using all predictors from the regression
models is good.
Bidirectional Regulatory Networks
Until now, we focused on the regulation of genes via the
expression of miRNAs. The expression of the miRNAs themselves
is under the control of genes, such as transcription factors and their
mediators. Together this yields a bidirectional regulatory interplay
of gene expression and miRNA expression.
We complemented our analysis by running the same analysis to
predict miRNA expression from mRNA expression, yielding
modules of mRNAs as predictors of miRNA expression. We
identified 93 miRNAs whose expression could be significantly
predicted from gene expression (File S6). The reverse models also
exploit the joint information of multiple predictors. A summary of
the prediction performance of the reverse models is given in
Table 1.
Restricting gene models to the direct target and residual models
where only negative coefficients are permitted and leaving the
reverse models (genes predicting miRNA expression) uncon-
Figure 2. Scaled mean squared cross-validated prediction error
(cv-SMSE) of unconstrained models with correct sample lables
(green) and of models with permuted sample labels (black). The
range of the cv-SMSE is shown on the horizontal axis, while the density
is shown on the vertical axis. The lines indicate the density of the data
distributions, and small vertical stripes display individual data points.
doi:10.1371/journal.pone.0040634.g002
Table 1. Performance of the different types of gene and miRNA models.
Gene models
number of sign.
models
cv-SMSE (0.05, 0.5,
0.95 quantile)
difference in r (0.05
and 0.95 quantile)
number of predictors,
median
Unconstrained 928 0.3998 0.6488 0.7871 20.1719 0.1533 2–55; 31
Direct target (DTM) 480 0.5739 0.7637 0.8743 20.3541 0.3552 1–45; 6
Residual 581 0.3564 0.6305 0.7903 20.1641 0.1687 1–57; 29
Negative regulation and direct target 716 0.6777 0.8936 0.9717 20.4552 0.4073 1–26; 3
Negative regulation, residual 689 0.2052 0.7039 3.9824 20.6058 0.5700 1–54; 24
miRNA model, unconstrained 93 0.3493 0.5844 0.7872 20.1099 0.1139 8–54; 37
Number of significant models, scaled mean squared prediction error from cross-validation (cv-SMSE), 0.05 and 0.95 quantile of the differences in gene-wise correlation
between original and predicted gene expression, and range and median of number of predictors for each model type.
doi:10.1371/journal.pone.0040634.t001
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strained, yields a bidirectional regulatory network comprised of
2,985 nodes and 23,513 edges in total. This large network can be
best browsed by focusing on subnetworks centered around specific
genes or miRNAs.
Focusing on the subnetwork around miR-19b-1, some of the
genes for which miR-19b-1 serves as a predictor are known to
have binding sites (11 genes), but the majority of the genes were de
novo identified (50 genes).
The three most significant GO terms from the target gene over-
representation analysis of miR-19b-1 are ‘DNA recombination’,
‘DNA repair’ and ‘programmed cell death’ (Table 3). This
confirms the known role of miR-19b-1 in apoptosis and points to
further functions of miR-19b-1 targets in DNA recombination and
repair which are also often dysregulated in cancer. Figure 4 shows
the subnetwork of genes involved in the three GO categories
mentioned above. Interestingly, only three of the genes are
predicted to be targets of miR-19b-1 based on sequence
information (rectangular nodes), the others are not in the
databases (ellipsoid gene nodes) and stem from the residual
models. Therefore, the GO term enrichment analysis was driven
by the newly identified genes. Among these genes, TFPT (alias
FB1, ‘TCF3 (E2A) fusion partner (in childhood Leukemia)’) is
annotated with all three of the GO terms selected and a known
proto-oncogene in childhood pre-B acute lymphoblastic leukemia
[36]. RUVBL1 (alias TIP49) has been shown to be a co-factor of
Myc and as such modulates apoptosis in c-Myc-mediated
oncogenesis, e.g., in lymphomas [37].
Co-transcription of Genes and miRNAs
Several miRNAs are located within the coding region of a gene.
These miRNAs are under the same transcriptional control as their
host genes and therefore, if at all, we expect a positive regulatory
effect. One does not need regression modeling to identify these
miRNAs. Nevertheless, they constitute a small but good test
framework for our models; we expect to find these pairs of genes
and miRNAs and the resulting correlation coefficients to be
positive.
Using positional information from the ensembl database
(http://www.ensembl.org), we selected genes hosting one or
several miRNAs and kept those pairs for which the mRNA is
represented on the HGU133A microarray and the miRNA on the
custom microarray used here. In unconstrained gene models in
which a miRNA from the same locus as the gene served as one of
the predictors, we only found positive coefficients. Likewise, in
miRNA models, the coefficients of genes serving as one of the
predictors for a miRNA from the same locus were always positive.
Discussion
The NCI-60 data set is one of the most extensively studied data
sets available and has emerged as a well recognized resource for
cancer research and the development of computational tools.
miRNA expression was first assessed by Blower [38] using custom
spotted microarrays and by Gaur [39] using qPCR. Later, Liu
[40], and Søkilde [41] used commercial platforms for miRNA
profiling. Comparing the aforementioned platforms, Søkilde [41]
found high concordance between the miRNA platforms, especially
compared to a similar analysis on mRNA data of the NCI-60 data
panel [42]. All analyses showed tissue specific expression of
characteristic miRNAs which led to a separation of samples
according to their tissue of origin in hierarchical clustering. Søkilde
[41] defined tissue-specific miRNAs as the ones with significantly
higher expression in the respective tissue compared to the
remaining tissues. They found miR-19b tissue-specific for leuke-
mias and colon and these two tissues of origin also show highest
and second highest expression in the miRNA expression data of
Blower [38], which we use.
From the perspective of target prediction, data-based regression
approaches are complementary to existing sequence-based
approaches. Sequence-based approaches are limited to direct
interactions between miRNAs and mRNA transcripts, they might
identify functionally inactive interactions, and they can not capture
regulatory interplay through the co-expression of genes and
miRNAs. The regression approaches on the other hand do not
suffer from any of these limitations. First, it is more likely to
capture functional interactions by taking expression profiles into
account. Second, regression captures indirect regulation where the
miRNA has an effect on an intermediate player, which then affects
the mRNA levels observed. Third, regulation by mechanisms not
yet described can be captured. This is advantageous from the
systems biology perspective but disadvantageous from the
perspective of understanding regulatory mechanisms on the level
of molecular interactions. It is important to note that there is a
conceptual difference between the notion of a predictor and that of
Figure 3. Gene expression of genes for which miR-19b-1 serves as one of the predictors. A) Gene expression values. B) Gene expression
predicted from miR-19b-1 only. C) Gene expression predicted from all predictors of the gene models. Gene expression can only be predicted if all
predictors of the direct target and the residual model are used. If only miR-19b-1 is allowed as a predictor in the LARS model, the prediction is poor. In
all subfigures, samples are in rows and genes in columns. Expression and predicted expression values were centered and scaled and color-coded with
blue representing low and yellow high expression values. The order of genes and samples is the same for all sub-figures.
doi:10.1371/journal.pone.0040634.g003
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a regulator. Although regression is directional in the sense that the
role of predicting variables and predicted variables is different, this
must not be interpreted as modeling causal interactions. Regres-
sion captures correlation of expression values, which can arise in
many ways. A gene can regulate a miRNA, the miRNA can
regulate the gene, or a third molecule, miRNA or gene, can
regulate both of them. The picture becomes even more
complicated when several molecules regulate a target in concert.
While it is an advantage of the regression-based approach to be
sensitive to all these forms of functional regulation, it is a
disadvantage that regression can not distinguish between them.
This in contrast is a strength of the sequence based target
prediction approach. It builds on the molecular mechanisms of
mRNA degradation at the RISC complex [43] and hence captures
causal regulation mechanisms.
A general advantage of expression data-based approaches is that
they are more likely to capture context specific functional
interactions. miRNA mediated gene regulation can change during
cell differentiation and oncogenic transformation, while sequence
patterns do not. Regulation events require that a miRNA and an
mRNA are expressed at the same time in the same compartment
of a cell, since the miRNA must physically bind to the mRNA.
This may be the case in one type of cells and not in another.
Moreover all necessary proteins to form a RISC complex need to
be present, which might also not be given at all times and
locations. In addition, cell specific alternative splicing and
polyadenylation can remove regulatory sites from the gene
transcript and lead to different gene regulation, as observed in
proliferating cells which have shorter 39-UTRs with less miRNA
binding sites [44]. Furthermore, examples show that miRNA-
Table 3. Most frequent GO terms over-represented in targets of miR-19b-1.
GOBPID p-value odds ratio expected count count size term
GO:0006310 0.0033 8.48 0.67 4 14 DNA recombination
GO:0006281 0.0071 4.96 1.27 5 27 DNA repair
GO:0012501 0.0074 2.37 7.87 15 164 programmed cell death
GO:0006513 0.0128 20.55 0.19 2 4 protein monoubiquitination
GO:0016064 0.0128 20.55 0.19 2 4 immunoglobulin mediated immune
response
GO:0016574 0.0128 20.55 0.19 2 4 histone ubiquitination
GO:0022408 0.0128 20.55 0.19 2 4 negative regulation of cell-cell adhesion
GO:0030325 0.0128 20.55 0.19 2 4 adrenal gland development
GO:0051385 0.0128 20.55 0.19 2 4 response to mineralocorticoid stimulus
GO:0000209 0.0130 5.27 0.96 4 20 protein polyubiquitination
GO:0042981 0.0136 2.37 6.10 12 127 regulation of apoptotic process
GO:0016265 0.0158 2.13 8.54 15 178 death
GO:0070507 0.0169 6.94 0.58 3 12 regulation of microtubule cytoskeleton
organization
GO:0043525 0.0206 13.69 0.24 2 5 positive regulation of neuron apoptosis
GO:0033554 0.0212 2.28 5.71 11 121 cellular response to stress
GO:0010564 0.0216 3.14 2.26 6 47 regulation of cell cycle process
GO:0010942 0.0289 2.65 3.07 7 65 positive regulation of cell death
GO:0010557 0.0296 2.23 5.23 10 109 positive regulation of macromolecule
biosynthetic process
GO:0007052 0.0300 10.25 0.29 2 6 mitotic spindle organization
GO:0031328 0.0315 2.12 6.05 11 126 positive regulation of cellular biosynthetic
process
GO:0009893 0.0319 1.96 8.45 14 176 positive regulation of metabolic process
GO:0045935 0.0351 2.15 5.38 10 112 positive regulation of nucleobase-
containing compound metabolic process
GO:0052548 0.0366 3.64 1.30 4 27 regulation of endopeptidase activity
GO:0009416 0.0384 8.48 0.33 2 7 response to light stimulus
GO:0002449 0.0407 8.20 0.34 2 7 lymphocyte mediated immunity
GO:0007613 0.0407 8.20 0.34 2 7 memory
GO:0009411 0.0407 8.20 0.34 2 7 response to UV
GO:0007093 0.0441 4.44 0.82 3 17 mitotic cell cycle checkpoint
GO:0033043 0.0468 2.55 2.69 6 56 regulation of organelle organization
GO:0065009 0.0469 1.84 8.88 14 185 regulation of molecular function
GOBPID stands for the Gene Ontology Biological Process identifier. P-value, odds ratio, expected and observed count are taken from the hypergeometric test for each
GO term.
doi:10.1371/journal.pone.0040634.t003
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mediated repression can be altered in response to changing
environmental conditions [45]. There might be even more cell
specific factors influencing the interplay between miRNA and
mRNA which are waiting to be discovered. In many cases, it is still
unclear in which context a miRNA can functionally bind to a gene
transcript. While in some contexts, all necessary factors might be
present, in others, binding could be prevented because conditions
are not adequate. Here lies an additional strength of the paired
profiles approach. It can take cellular contexts into account by
selecting gene and miRNA expression datasets from cells or tissues
under different conditions. Although the NCI-60 data hold
samples from many diverse cellular contexts, these subsets are
too small to be analyzed separately. Nevertheless, the approach
can be used once larger paired gene-miRNA data sets are
available. This will allow for finding functional interactions in
specific contexts.
In principle, the LARS approach shown here is very similar to
the Bayesian modeling approach by [17]. These authors use gene
expression profiles of mRNAs and miRNAs, plus miRNA seed
sequence information in a Bayesian model. In a follow-up
publication [18], they also include mRNA sequence features in
the model, but this added little to the total accuracy of their
predictions. Very recently, Lu et al. ([19]) proposed a LASSO
regression model considering miRNA and mRNA expression
profiles, miRNA binding site information, and availability of the
RISC complex. They could show that the LASSO regression
model is powerful in refining sequence based miRNA target
predictions. However, constraining on the occurrence of a seed
Figure 4. Interaction network of miR-19b-1. Interactions of miR-19b-1 with genes with functions in ‘DNA recombination’ (orange), ‘DNA repair’
(pink), ‘programmed cell death’ (green), all three categories (yellow), in ‘DNA recombination’ and ‘DNA repair’ (purple) and in ‘DNA recombination’
and ‘programmed cell death’ (red). miR-19b-1 is located in the center of the network, around it are genes for which miR-19b-1 is one of the predictors
from the negative restricted models (NRM) and the third layer consists of miRNAs for which the genes from the second layer are predictors
(unconstrained models). Genes from direct target NRM models (miR-19b-1 is predicted to target the gene by at least two miRNA target prediction
algorithms) are represented by rectangular nodes. Genes from residual models have ellipsoid nodes. TFPT: TCF3 (E2A) fusion partner (in childhood
Leukemia) [HGNC:13630]; POLR2E: polymerase (RNA) II (DNA directed) polypeptide E, 25 kDa [HGNC:9192]; MDK: midkine (neurite growth-promoting
factor 2) [HGNC:6972]; PSMA2: proteasome (prosome, macropain) subunit, alpha type, 2 [HGNC:9531]; SWAP70: SWAP switching B-cell complex
70 kDa subunit [HGNC:17070]; PLK2: polo-like kinase 2 [HGNC:19699]; CTGF: connective tissue growth factor [HGNC:2500]; UBE2B: ubiquitin-
conjugating enzyme E2B [HGNC:12473]; NGFRAP1:nerve growth factor receptor (TNFRSF16) associated protein 1 [HGNC:13388]; TPX2: TPX2,
microtubule-associated, homolog (Xenopus laevis) [HGNC:1249]; PRKCD: protein kinase C, delta [HGNC:9399]; RUVBL1: RuvB-like 1 (E. coli)
[HGNC:10474]; AGRN: agrin [HGNC:329]; NR3C1: nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) [HGNC:7978]; HUWE1:
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase [HGNC:30892]; RRAGA: Ras-related GTP binding A [HGNC:16963]; USP1:
ubiquitin specific peptidase 1 [HGNC:12607]; RPS6KA3: ribosomal protein S6 kinase, 90 kDa, polypeptide 3 [HGNC:10432]; DUSP1: dual specificity
phosphatase 1 [HGNC:3064]; PHLDA3: pleckstrin homology-like domain, family A, member 3 [HGNC:8934].
doi:10.1371/journal.pone.0040634.g004
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sequence in both approaches did not allow finding interactions
based on non-canonical, not perfectly matching target site reliant,
mechanisms.
In summary, we have presented a regression analysis of paired
gene and miRNA profiles. We have shown that miRNA
expression can predict gene expression with high accuracy and,
likewise, that miRNA expression can be predicted from gene
expression. Moreover, we provide lists of potential functional
targets for a large set of miRNAs including both known targets
with one or several miRNA binding sites, and previously
unidentified targets lacking a canonical seed binding site. In
almost all instances multiple miRNA predictor models yielded
better predictive performances than single miRNA models. This
observation suggests that miRNA mediated regulation can not be
reduced to individual miRNA-mRNA interactions.
Methods
Data Analysis and Computational Approach
Data preprocessing. We used data from 59 cell lines of
the NCI-60 panel for which paired mRNA and miRNA
expression profiles were available. The mRNA expression raw
data (Affymetrix hgu133a microarrays) was downloaded from
the ArrayExpress database (http://www.ebi.ac.uk/microarray-
as/ae/, accession number E-GEOD-5720) and normalized using
the VSN algorithm [46]. Internal control probe sets (identifiers
starting with ‘AFFX’ and probe sets mapping multiple different
transcripts (ending with ‘_x_at’) were removed and remaining
probe sets were mapped on to entrez identifiers. Whenever
more than one probe set mapped to the same entrez identifier,
the one with higher mean expression across samples was
retained. This procedure yielded 12,196 probe sets targeting one
entrez gene each. We then discarded probe sets that showed
little variation across samples and kept those 40% of probe sets
with the highest inter-quartile range (4,878 probe sets).
The miRNA data set from Blower et al. [38] was used. miRNA
preprocessed expression data was also obtained from ArrayEx-
press, accession number E-MEXP-1029, and quantile normalized
[47]. (Note: until March 2012, preprocessed data was available
under the mentioned accession number. After Mar 2012, only raw
data is provided. The preprocessing procedure is described in
Blower et al. [38]). For the miRNA probes, a non-specific filtering
step requiring at least 20 of the 59 samples to have unique
measurements excluded all miRNA probes with constant expres-
sion levels across the majority of samples (443 of 627 miRNA
probes remained). Whenever there was more than one probe
targeting the same miRNA, the probe with the higher mean
expression across samples was retained. This procedure yielded
expression values for 311 different miRNAs that went into
modeling. All analyzes were performed in R [48] and Biocon-
ductor [49]. For simplicity of presentation, we describe our
statistical analysis for the case of predicting gene expression from
miRNA expression. Predicting miRNA expression from gene
expression is done analogously.
Least Angle Regression
We applied least angle regression [30], a computational efficient
variant of linear regression with an L1-regularization term
(LASSO variant, [50]). L1-regularization does not only avoid
over-fitting of high-dimensional regression models but also yields a
selection of miRNA predictors, since the sum of the absolute
values of the regression coefficients is constrained to be below t.
The constraining L1-regularization can be represented by the
following inequality:
Xpj
k~1
Db^jk Dvt ð1Þ
In the unconstrained models, pj consists of all k miRNAs
irrespective of sequence information. In the constrained models,
the set of miRNAs potentially predicting a mRNA is different for
each mRNA, and the set of potentially targeting miRNAs pj ,
depends on mRNA j (response variable). Thus b^jk denote the fitted
regression coefficients of miRNAs k in the set of miRNAs
potentially targeting mRNA j, and t is the constraint value.
Introducing a Lagrange multiplier into linear regression, the
estimate for b^jk becomes:
b^jk~
1
2
XN
l~1
yj{bj0{
Xpj
k~1
bjkx
l
jk
 !2
zl
Xpj
k~1
bjk
  ð2Þ
Furthermore, yj indicates the expression level of the j-th mRNA,
xlj,k represent the expression level of the k-th miRNA in sample l
potentially targeting the j-th mRNA.
The constraint shrinks coefficients toward zero and many of
them turn out to be exactly zero, which are subsequently filtered
out. The shrinking parameter l tunes the number of miRNAs
remaining in the model. If it is small, many miRNAs are left. If it is
large, most of them are filtered out.
For each regression model, we tuned l by minimizing the mean
squared prediction error (MSE) in a 10-fold cross-validation. One
separate model was learned for every predicted gene thus
identifying a set of predictor miRNAs for it. Predictors which
had entered a model are reported as candidate regulators. All
predictions were merged to a predicted expression profile.
In the prevalent conception of miRNA-mediated gene regula-
tion the miRNA is negatively regulating the expression of a gene.
We reflect this in the NRM regression models by only allowing
negative regression parameters except for the intercept. In view of
the results of Vasudevan and coworkers [26,27] we also ran our
analysis without the parameter restriction.
Lars-LASSO regression models were implemented with the
help of the R package ‘lars’ [51].
Integration of targeting information. In order to integrate
miRNA targeting information in the regression modeling, we
implemented a two step procedure. First we restricted the set of
possible predictors for a specific mRNA to the miRNAs reported
in a collection of miRNA target databases: TargetScan [3], version
6.1, microCosm (based on miRBase) version 5 [12], doRiNA
(formerly PicTar), downloaded all miRNA targets using the web
server on Mar 30, 2012 [28], and DIANA-microT, version 3.0
[29] as potential binding partners of the mRNA. All miRNAs
predicted to target a specific gene by at least two of the four
algorithms were taken as potential regulators, and a model was fit
as discussed above. An overview over the number of interactions
predicted by the four miRNA target prediciton algorithms for the
genes and miRNAs of the NCI-60 dataset used in this analysis, and
the overlap between the different algorithms can be found in
Figure S1. For the negative constraint models, the ‘lars’ and
‘cv.lars’ functions of the ‘lars’ R package were modified
analogously to the positive constraint lars described in Efron et
al. [30]. In principle, when searching for the next predictor to
enter the model, instead of using absolute current correlations,
Modeling miRNA-mRNA Interactions
PLoS ONE | www.plosone.org 10 July 2012 | Volume 7 | Issue 7 | e40634
only negative current correlations were considered. This proce-
dure yielded negative coefficients (bjk) only. The code of the
modified functions is provided in the supporting information
section (File S7).
Finding interactions based on alternative regulatory
mechanisms. In order to discover new regulators beyond those
annotated in the miRNA target databases, we trained a second
class of models on the residuals of the first. This time we used all
but the miRNA probes from the first run as potential predictors.
For the genes without any regulating miRNAs reported in the
database, a model without targeting restrictions was fitted at this
time.
Evaluation. Our method generates lists of candidate regula-
tors even if the data holds no information on them. However, in
this case the regression models have a very poor predictive
performance. In order to evaluate predictive performance, we
contrasted the observed cv-MSE with a simulated distribution of
cv-MSEs that the same procedure generates if the expression
profiles are not properly paired.
We did this by running our procedure on data where the
samples were randomly permuted in one data set such that
‘‘paired’’ samples no longer stem from the same cell line. In other
words, we tried to predict the expression profile of a cell line from
the miRNA profile of another cell line, which can only result in
random predictions. For every gene and each modeling approach,
we learned 100 models with permuted pairings. For every
predicted gene, we recorded the cv-MSE across the 100
permutations of each type of model and calculated an empirical
p-value for the observed cv-MSE by counting the relative
frequency of permutation based cv-MSEs that were smaller than
the cv-MSE of the correctly paired data. Optimization of the
shrinkage parameter l was repeated for every permutation and the
optimal value could be different to the original one and varied
across permutations.
We did not see major differences in p-values when comparing
two sets of 100 permutations and thus limited permutations in
view of the high computational cost of calculating hundreds of
thousands of regression models (about 12 hours per permutation
on a dual-core AMD with 2.2 GHz and 32 GiB RAM cluster
node when modeling all genes).
From the distributions of p-values, False Discovery Rates (FDR)
were estimated [31] and a list of top ranking models with FDR
,0.01 was considered for further analysis.
Graphical Representation of Expression Matrices
For Figures 1 (A) and 1 (B), gene expression values and gene
expression values predicted with miRNA expression using the
unconstrained LARS regression model were centered and scaled,
and genes and samples of the gene expression data were
hierarchically clustered using Manhattan distance and average
linkage. The gene expression values predicted with miRNA
expression (Figure 1 (B)) were plotted in the same order as the
original gene expression data. The gene-wise correlation matrix of
gene expression (Figure 1 (C)) was hierarchically clustered using
Manhattan distance and average linkage and the correlation
matrix of the gene expression values predicted with miRNA
expression (Figure 1 (D)) was plotted using the same order of genes.
In Figure 3 (A), the expression values of all genes for which miR-
19b-1 served as a predictor in either the direct target or the
residual models were centered and scaled and then clustered with
Euclidean distance and Ward linkage. The gene expression values
of these genes were then predicted with either miR-19b-1 alone
(Figure 3 (B)) or with all predictors included in the direct target and
residual models (Figure 3 (C)).
Over-representation of Functional Groups among
Oncomir Targets
miRNA probes for the oncomirs presented in table 1 of Esquela-
Kerscher [33] were selected from the NCI-60 miRNA microarray.
For finding over-represented GO terms in potential oncomir
targets, a conditional hypergeometric test from the Bioconductor
package ‘GOstats’ [52] was applied to the targets of each
individual oncomir probe. The conditional test takes into account
the graph structure of Gene Ontology terms and conditions on all
child nodes when testing a specific node, therefore requiring
significance of the node beyond what is provided by the child
nodes. P-value histograms of the conditional and the regular
hypergeometric test can be found in Figure S2. Both show
significance by an accumulation of low p-values, but the
frequencies are lower for the conditional test because the overlap
of terms has been accounted for. The ontology ‘Biological Process’
was used. GO categories with size smaller than 10 were excluded.
All 1364 genes (from 716 negative regulation and 689 residual
models, minus the duplicate genes and genes without a GO term)
for which we found significant prediction models served as the
gene universe, conceptually representing the collection of genes
from which genes could be selected to be predicted by individual
miRNAs. mRNA probes had to be mapped to entrez identifiers
and duplicate entrez identifiers were removed prior to the
hypergeometric test.
For each oncomir probe, we considered GO terms with a p-
value ,0.05 as significant. The most frequently occurring GO
terms over all models are summarized in Table 2. GO term
enrichment analysis for the genes from negative regulation and
residual models where miR-19b-1 served as a predictor was done
analogously. All genes from the negative regulation and residual
models served as the gene universe. Small categories (,10 genes)
were not excluded.
Supporting Information
Figure S1 Overlap of miRNA target gene predictions.
Overlap of predicted miRNA target genes from four different
prediction algorithms (microCosm/miRBase, TargetScan, DI-
ANA/microT, PicTar/DoRiNA) Numbers show miRNA-gene
pairs represented in the NCI-60 dataset used here.
(PDF)
Figure S2 p-value histograms of GO term analysis. p-
value histograms of hypergeometric testing of oncomirs for over-
representation of GO terms. Left: standard hypergeometric test,
right: conditional test. Both histograms show enrichment of terms
with low p-values, but the one of the conditional test has lower
numbers because terms called significant because of child terms
are omitted.
(PDF)
File S1 Unconstrained gene models. miRNA predictors
and coefficients for genes with a significant unconstrained model
in tabular format (csv). Coefficients were estimated from the
centered and scaled miRNA expression data.
(CSV)
File S2 Direct target gene models. miRNA predictors and
coefficients for genes with a significant DTM in tabular format
(csv). Coefficients were estimated from the centered and scaled
miRNA expression data.
(CSV)
File S3 Residual gene models. miRNA predictors and
coefficients for genes with a significant residual model in tabular
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format (csv). Coefficients were estimated from the centered and
scaled miRNA expression data.
(CSV)
File S4 Negative regulation direct target gene models.
miRNA predictors and coefficients for genes with a significant
negative regulation direct target model in tabular format (csv).
Coefficients were estimated from the centered and scaled miRNA
expression data.
(CSV)
File S5 Negative regulation residual gene models.
miRNA predictors and coefficients for genes with a significant
negative regulation residual model in tabular format (csv).
Coefficients were estimated from the centered and scaled miRNA
expression data.
(CSV)
File S6 Unconstrained miRNA models. Gene predictors
and coefficients for miRNAs with a significant unconstrained
model in tabular format (csv). Coefficients were estimated from the
centered and scaled mRNA expression data.
(CSV)
File S7 R code of all analyses. zip archive of R scripts to
compute the models and analyses as well as modified lars
functions.
(ZIP)
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